Page last updated: 2024-09-03

thiodigalactoside and Experimental Neoplasms

thiodigalactoside has been researched along with Experimental Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blanchard, H; Cutler, S; Dong, LF; Ito, K; Neuzil, J; Ralph, SJ; Scott, SA	1

Other Studies

1 other study(ies) available for thiodigalactoside and Experimental Neoplasms

Article	Year
Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress. Angiogenesis, 2011, Volume: 14, Issue:3 Topics: Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Drug Resistance, Neoplasm; Endothelial Cells; Female; Galectin 1; Gene Knockdown Techniques; Immunity, Cellular; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Neovascularization, Pathologic; Oxidative Stress; Thiogalactosides	2011

Article

Year

Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.

Angiogenesis, 2011, Volume: 14, Issue:3

Topics: Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Drug Resistance, Neoplasm; Endothelial Cells; Female; Galectin 1; Gene Knockdown Techniques; Immunity, Cellular; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Neovascularization, Pathologic; Oxidative Stress; Thiogalactosides

2011